Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

LXEOLexeo Therapeutics, Inc.

Nasdaq · CIK 0001907108
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC2836 Biological Products, (No Diagnostic Substances)
FY end1231
XBRL facts202

Identity from submissions API

NameLexeo Therapeutics, Inc.
CIK0001907108
TickersLXEO
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC2836 Biological Products, (No Diagnostic Substances)
EIN854012572
LEI—
Fiscal year end1231
State of incorporation—
Phone(212) 547-9879
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
345 PARK AVENUE SOUTH
FLOOR 6
NEW YORK
NY
10010
NY
Mailing address
345 PARK AVENUE SOUTH
FLOOR 6
NEW YORK
NY
10010
NY

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

378 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-18 4 xslF345X06/form4-11182026_051106.xml 0002083206-26-000011 5480
2026-11-18 4 xslF345X06/form4-11182026_051104.xml 0002024096-26-000017 5532
2026-11-18 4 xslF345X06/form4-11182026_051101.xml 0001995218-26-000019 5544
2026-11-17 4 xslF345X06/form4-11172026_101144.xml 0001678984-26-000005 5676
2026-11-17 3 xslF345X06/form3-11172026_101105.xml 0001678984-26-000004 7850
2026-11-17 144 xsl144X01/primary_doc.xml 0001959173-26-008104 001-41855 261565861 33 5205
2026-11-17 144 xsl144X01/primary_doc.xml 0001959173-26-008101 001-41855 261565831 33 5073
2026-11-17 144 xsl144X01/primary_doc.xml 0001959173-26-008097 001-41855 261565738 33 5117
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000947871-26-001037 005-94231 261563373 34 15099
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000902664-26-004577 005-94231 261561230 34 11296
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-128311 005-94231 261560942 34 12260
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001274173-26-000240 005-94231 261558088 34 13090
2026-11-16 10-Q 10-Q 0001193125-26-462020 001-41855 261555357 34 13683602 1 1
2026-11-16 8-K 8-K 2.02,7.01,8.01,9.01 0001193125-26-462015 001-41855 261555352 34 28949212 1 1
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-005050 005-94231 261555108 34 15713
2026-11-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001011438-26-000696 005-94231 261552769 34 10850
2026-11-10 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000093751-26-000685 005-94231 261538106 34 7971
2026-11-04 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-003444 333-299689 261524453 33 1746
2026-10-29 S-3 S-3 0001193125-26-437001 333-299689 261497508 33 890279 1 1
2026-10-13 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000019617-26-000349 005-94231 261456256 34 6659
2026-09-29 8-K 8-K 2.01,3.02,9.01 0001193125-26-407555 001-41855 261424072 34 184907 1 1
2026-09-28 4 xslF345X06/form4-09282026_050908.xml 0002083206-26-000009 5628
2026-09-28 4 xslF345X06/form4-09282026_050906.xml 0002109299-26-000009 7557
2026-09-28 4 xslF345X06/form4-09282026_050904.xml 0002024096-26-000015 7603
2026-09-28 4 xslF345X06/form4-09282026_050901.xml 0001995218-26-000017 7618
2026-09-22 8-K 8-K 1.01,8.01,9.01 0001193125-26-397221 001-41855 261395232 34 8630822 1 1
2026-08-19 4 xslF345X06/form4-08192026_050809.xml 0002083206-26-000007 5482
2026-08-19 4 xslF345X06/form4-08192026_050805.xml 0001995218-26-000015 5546
2026-08-19 4 xslF345X06/form4-08192026_050801.xml 0002024096-26-000013 5534
2026-08-18 144 xsl144X01/primary_doc.xml 0001959173-26-006154 001-41855 261290182 33 5843
2026-08-18 144 xsl144X01/primary_doc.xml 0001959173-26-006153 001-41855 261290154 33 5750
2026-08-18 144 xsl144X01/primary_doc.xml 0001959173-26-006152 001-41855 261290102 33 5073
2026-08-14 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000947871-26-000801 005-94231 261283956 34 15511
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-097207 005-94231 261282222 34 12445
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-003428 005-94231 261275817 34 15712
2026-08-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001011438-26-000515 005-94231 261273482 34 9646
2026-08-12 10-Q 10-Q 0001193125-26-345724 001-41855 261265290 34 11692731 1 1
2026-08-12 8-K 8-K 2.02,8.01,9.01 0001193125-26-345722 001-41855 261265282 34 18840589 1 1
2026-08-07 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000093751-26-000489 005-94231 261252003 34 8097
2026-07-01 4 xslF345X06/form4-07012026_100733.xml 0002083206-26-000005 7036
2026-07-01 4 xslF345X06/form4-07012026_100702.xml 0002024096-26-000011 7089
2026-07-01 4 xslF345X06/form4-07012026_100718.xml 0002109299-26-000007 7044
2026-07-01 4 xslF345X06/form4-07012026_100715.xml 0001995218-26-000013 7105
2026-07-01 144 xsl144X01/primary_doc.xml 0001959173-26-005036 001-41855 261146174 33 5122
2026-07-01 144 xsl144X01/primary_doc.xml 0001959173-26-005033 001-41855 261145984 33 4441
2026-07-01 144 xsl144X01/primary_doc.xml 0001959173-26-005032 001-41855 261145982 33 4459
2026-07-01 144 xsl144X01/primary_doc.xml 0001959173-26-005031 001-41855 261145960 33 5211
2026-06-29 8-K 8-K 5.07 0001193125-26-288703 001-41855 261136792 34 162956 1 1
2026-06-29 4 xslF345X06/form4-06292026_080651.xml 0001458116-26-000002 5653
2026-06-29 4 xslF345X06/form4-06292026_080602.xml 0001722234-26-000002 5664
2026-06-29 4 xslF345X06/form4-06292026_080620.xml 0001931514-26-000002 5668
2026-06-29 4 xslF345X06/form4-06292026_080624.xml 0001250086-26-000002 5635
2026-06-29 4 xslF345X06/form4-06292026_080640.xml 0001849458-26-000001 5640
2026-06-29 4 xslF345X06/form4-06292026_080640.xml 0001816206-26-000005 5657
2026-06-29 4 xslF345X06/form4-06292026_080630.xml 0001193675-26-000002 5693
2026-06-15 8-K 8-K 7.01,8.01,9.01 0001193125-26-270275 001-41855 261089016 34 24203296 1 1
2026-05-20 4 xslF345X06/form4-05202026_040507.xml 0002024096-26-000009 5534
2026-05-20 4 xslF345X06/form4-05202026_040505.xml 0001995218-26-000011 5546
2026-05-18 144 xsl144X01/primary_doc.xml 0001959173-26-003723 001-41855 26992770 33 5212
2026-05-18 144 xsl144X01/primary_doc.xml 0001959173-26-003717 001-41855 26992691 33 5129
2026-05-18 144 xsl144X01/primary_doc.xml 0001959173-26-003716 001-41855 26992685 33 5101
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-062613 005-94231 26988222 34 12440
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-225157 005-94231 26981982 34 142091
2026-05-11 10-Q 10-Q 0001193125-26-215678 001-41855 26960834 34 10202743 1 1
2026-05-11 8-K 8-K 2.02,8.01,9.01 0001193125-26-215674 001-41855 26960826 34 17108284 1 1
2026-04-30 4 xslF345X06/form4-04302026_080451.xml 0001777421-26-000003 5680
2026-04-30 3 xslF345X06/form3-04302026_080417.xml 0001777421-26-000002 7933
2026-04-30 ARS ARS 0001193125-26-193939 001-41855 26920011 34 1722298
2026-04-30 DEFA14A DEFA14A 0001193125-26-193935 001-41855 26920002 34 999966
2026-04-30 DEF 14A DEF 14A 0001193125-26-193930 001-41855 26919990 34 2222599
2026-04-30 8-K 8-K 5.02 0001193125-26-193927 001-41855 26919974 34 159277 1 1
2026-04-13 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-002223 005-94231 26858436 34 16788
2026-04-07 4 xslF345X06/form4-04072026_040401.xml 0001995218-26-000009 5726
2026-04-06 144 xsl144X01/primary_doc.xml 0001968582-26-000351 001-41855 26841312 33 4488
2026-03-30 S-8 S-8 0001193125-26-132423 333-294751 26815567 33 470582 1 1
2026-03-30 10-K 10-K 0001193125-26-132085 001-41855 26813842 34 18365497 1 1
2026-03-30 8-K 8-K 2.02,8.01,9.01 0001193125-26-131792 001-41855 26813145 34 16988264 1 1
2026-03-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-001619 005-94231 26801837 34 7163
2026-03-17 4 xslF345X05/form4-03182026_010332.xml 0001995218-26-000006 5079
2026-03-17 4 xslF345X05/form4-03182026_010330.xml 0002024096-26-000007 5068
2026-02-20 4 xslF345X05/form4-02202026_050205.xml 0002024096-26-000005 5402
2026-02-20 4 xslF345X05/form4-02202026_050203.xml 0001995218-26-000004 5413
2026-02-20 4/A xslF345X05/form4a-02202026_050201.xml 0002024096-26-000004 5765
2026-02-18 144 xsl144X01/primary_doc.xml 0001959173-26-001161 001-41855 26648769 33 5211
2026-02-18 144 xsl144X01/primary_doc.xml 0001959173-26-001152 001-41855 26647989 33 5123
2026-02-18 144 xsl144X01/primary_doc.xml 0001959173-26-001143 001-41855 26647834 33 5194
2026-02-18 144 xsl144X01/primary_doc.xml 0001959173-26-001141 001-41855 26647746 33 5124
2026-02-18 144 xsl144X01/primary_doc.xml 0001959173-26-001140 001-41855 26647744 33 5102
2026-02-17 4 xslF345X05/form4-02172026_040201.xml 0002109299-26-000004 7600
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-26-016498 005-94231 26642566 34 18511
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-26-016355 005-94231 26640724 34 12350
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-26-052896 005-94231 26636155 34 127138
2026-02-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001231919-26-000153 005-94231 26634868 34 44905
2026-02-06 4 xslF345X05/form4-02062026_050205.xml 0001995218-26-000002 7654
2026-02-06 4 xslF345X05/form4-02062026_050203.xml 0002024096-26-000002 7642
2026-02-06 4 xslF345X05/form4-02062026_050201.xml 0002083206-26-000002 7601
2026-02-05 3 xslF345X02/form3-02052026_090214.xml 0002109299-26-000002 7760
2026-02-05 8-K 8-K 5.02 0001193125-26-039425 001-41855 26603117 34 153301 1 1
2026-01-30 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000102909-26-000183 005-94231 26582347 34 6961
2026-01-29 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001315863-26-000099 005-94231 26579987 34 15747
2026-01-27 8-K 8-K 5.02 0001193125-26-023339 001-41855 26562048 34 155969 1 1
2026-01-21 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0002012383-26-000688 005-94231 26545921 34 10743
2026-01-12 8-K 8-K 7.01,8.01,9.01 0001193125-26-010091 001-41855 26525540 34 22663349 1 1
2025-12-08 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000338 005-94231 251555164 34 9978
2025-11-26 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-003406 333-291269 251532236 33 1746
2025-11-26 424B3 424B3 0001193125-25-300634 333-291269 251530742 33 185628
2025-11-25 CORRESP filename1.htm 0001193125-25-297231 7702
2025-11-20 4 xslF345X05/form4-11202025_101125.xml 0001995218-25-000007 5407
2025-11-20 4 xslF345X05/form4-11202025_101109.xml 0001994972-25-000005 5361
2025-11-20 4 xslF345X05/form4-11202025_101104.xml 0002009350-25-000005 5426
2025-11-20 4 xslF345X05/form4-11202025_101103.xml 0001995009-25-000005 5369
2025-11-20 4 xslF345X05/form4-11202025_101149.xml 0002024096-25-000005 5375
2025-11-20 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-114635 005-94231 251503447 34 15880
2025-11-18 144 xsl144X01/primary_doc.xml 0001959173-25-007114 001-41855 251494316 33 5763
2025-11-18 144 xsl144X01/primary_doc.xml 0001959173-25-007113 001-41855 251494278 33 5823
2025-11-18 144 xsl144X01/primary_doc.xml 0001959173-25-007112 001-41855 251494269 33 5745
2025-11-18 144 xsl144X01/primary_doc.xml 0001959173-25-007110 001-41855 251494229 33 5729
2025-11-18 144 xsl144X01/primary_doc.xml 0001959173-25-007105 001-41855 251494100 33 5841
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-25-283019 005-94231 251486584 34 16158
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-004978 005-94231 251485466 34 11183
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000315 005-94231 251483729 34 10683
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-25-281249 005-94231 251480837 34 126592
2025-11-07 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-108535 005-94231 251463265 34 18215
2025-11-05 S-3 S-3 0001193125-25-265934 333-291269 251452041 33 433044 1 1
2025-11-05 S-8 S-8 0001193125-25-265784 333-291268 251451841 33 852189 1 1
2025-11-05 10-Q 10-Q 0001193125-25-265757 001-41855 251451822 34 13109101 1 1
2025-11-05 8-K 8-K 2.02,9.01 0001193125-25-265755 001-41855 251451802 34 687837 1 1
2025-10-27 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001346824-25-000027 005-94231 251419954 34 18996
2025-10-17 4 xslF345X05/form4-10172025_111028.xml 0002009350-25-000003 8973
2025-10-17 4 xslF345X05/form4-10172025_111049.xml 0001995009-25-000003 8915
2025-10-17 4 xslF345X05/form4-10172025_111011.xml 0002024096-25-000003 8921
2025-10-17 4 xslF345X05/form4-10172025_111047.xml 0001994972-25-000003 8907
2025-10-17 4 xslF345X05/form4-10172025_111000.xml 0001995218-25-000005 8939
2025-10-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002012383-25-002600 005-94231 251401854 34 10796
2025-10-17 8-K 8-K 1.01,2.02,3.02,8.01,9.01 0001193125-25-242652 001-41855 251401634 34 1041433 1 1
2025-10-17 424B5 424B5 0001193125-25-242649 333-283781 251401622 33 594533
2025-10-17 144 xsl144X01/primary_doc.xml 0001959173-25-006492 001-41855 251401186 33 5102
2025-10-17 144 xsl144X01/primary_doc.xml 0001959173-25-006487 001-41855 251401020 33 5126
2025-10-17 144 xsl144X01/primary_doc.xml 0001959173-25-006485 001-41855 251400995 33 5137
2025-10-17 144 xsl144X01/primary_doc.xml 0001959173-25-006484 001-41855 251400957 33 5207
2025-10-17 144 xsl144X01/primary_doc.xml 0001959173-25-006483 001-41855 251400930 33 5187
2025-10-17 FWP FWP 0001193125-25-241803 333-283781 251398836 34 22016
2025-10-16 424B5 424B5 0001193125-25-241560 333-283781 251398413 33 634911
2025-10-16 FWP FWP 0001193125-25-241436 333-283781 251397827 34 21955
2025-10-07 8-K 8-K 7.01,8.01,9.01 0001193125-25-232514 001-41855 251378177 34 11537001 1 1
2025-09-16 4 xslF345X05/form4-09162025_050903.xml 0001995218-25-000003 5080
2025-09-10 4/A xslF345X05/form4a-09102025_080929.xml 0001415889-25-024104 5333
2025-09-03 4 xslF345X05/form4-09032025_020901.xml 0001415889-25-023491 7599
2025-08-27 3 xslF345X02/form3-08272025_100828.xml 0001415889-25-023188 7968
2025-08-20 4 xslF345X05/form4-08202025_090801.xml 0001415889-25-022479 4901
2025-08-20 4 xslF345X05/form4-08202025_090842.xml 0001415889-25-022477 4894
2025-08-20 4 xslF345X05/form4-08202025_090811.xml 0001415889-25-022475 4886
2025-08-20 4 xslF345X05/form4-08202025_090813.xml 0001415889-25-022473 4914
2025-08-20 4 xslF345X05/form4-08202025_080818.xml 0001415889-25-022468 4951
2025-08-18 144 xsl144X01/primary_doc.xml 0001959173-25-005296 001-41855 251227702 33 4493
2025-08-18 144 xsl144X01/primary_doc.xml 0001959173-25-005294 001-41855 251227682 33 4478
2025-08-18 144 xsl144X01/primary_doc.xml 0001959173-25-005292 001-41855 251227675 33 4576
2025-08-18 144 xsl144X01/primary_doc.xml 0001959173-25-005291 001-41855 251227660 33 4558
2025-08-18 144 xsl144X01/primary_doc.xml 0001959173-25-005289 001-41855 251227656 33 4484
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-078747 005-94231 251220609 34 18417
2025-08-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-003607 005-94231 251218184 34 15387
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001415889-25-021791 005-94231 251217123 34 48695
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000249 005-94231 251216018 34 10683
2025-08-14 10-Q 10-Q 0000950170-25-108427 001-41855 251214361 34 11412894 1 1
2025-08-14 8-K 8-K 2.02,5.02,9.01 0000950170-25-108426 001-41855 251214359 34 710038 1 1
2025-08-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-25-180317 005-94231 251214173 34 136402
2025-08-07 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-075208 005-94231 251194354 34 18140
2025-07-01 424B3 424B3 0001193125-25-153484 333-288025 251094205 33 216683
2025-06-30 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-002095 333-288025 251094056 33 1746
2025-06-30 4 xslF345X05/form4-06302025_050616.xml 0001415889-25-018524 5502
2025-06-30 4 xslF345X05/form4-06302025_050614.xml 0001415889-25-018523 5519
2025-06-30 4 xslF345X05/form4-06302025_050611.xml 0001415889-25-018522 5497
2025-06-30 4 xslF345X05/form4-06302025_050609.xml 0001415889-25-018521 5530
2025-06-30 4 xslF345X05/form4-06302025_050606.xml 0001415889-25-018520 5555
2025-06-30 4 xslF345X05/form4-06302025_050604.xml 0001415889-25-018519 5508
2025-06-30 4 xslF345X05/form4-06302025_050601.xml 0001415889-25-018518 5526
2025-06-30 8-K 8-K 5.07 0000950170-25-091671 001-41855 251092777 34 161796 1 1
2025-06-27 CORRESP filename1.htm 0001193125-25-151402 7085
2025-06-26 CORRESP filename1.htm 0001193125-25-149103 31593
2025-06-26 S-3/A S-3/A 0001193125-25-149094 333-288025 251081101 33 320915
2025-06-18 UPLOAD filename1.pdf 0000000000-25-006429 333-288025 43531
2025-06-13 S-3 S-3 0001193125-25-140744 333-288025 251046600 33 340485
2025-06-05 DEFA14A DEFA14A 0000950170-25-082440 001-41855 251027834 34 17023
2025-06-04 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001415889-25-015606 005-94231 251023840 34 82759
2025-06-04 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001999371-25-007159 005-94231 251023088 34 9756
2025-05-27 8-K 8-K 1.01,3.02,7.01,9.01 0000950170-25-077377 001-41855 25984202 34 1803384 1 1
2025-05-20 4 xslF345X05/form4-05202025_050509.xml 0001415889-25-013819 4913
2025-05-20 4 xslF345X05/form4-05202025_050506.xml 0001415889-25-013818 4885
2025-05-20 4 xslF345X05/form4-05202025_050504.xml 0001415889-25-013817 4911
2025-05-20 4 xslF345X05/form4-05202025_050501.xml 0001415889-25-013816 4950
2025-05-16 144 xsl144X01/primary_doc.xml 0001959173-25-003281 001-41855 25958749 33 5179
2025-05-16 144 xsl144X01/primary_doc.xml 0001959173-25-003276 001-41855 25958719 33 5128
2025-05-16 144 xsl144X01/primary_doc.xml 0001959173-25-003275 001-41855 25958703 33 5185
2025-05-16 144 xsl144X01/primary_doc.xml 0001959173-25-003274 001-41855 25958696 33 5067
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-002358 005-94231 25949493 34 10837
2025-05-15 10-Q/A 10-Q/A 0000950170-25-071709 001-41855 25947592 34 2226371 1 1
2025-05-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000131 005-94231 25943813 34 10616
2025-05-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-069774 005-94231 25937068 34 141214
2025-05-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-002233 005-94231 25932839 34 12460
2025-05-12 10-Q 10-Q 0000950170-25-068536 001-41855 25932543 34 9545303 1 1
2025-05-12 8-K 8-K 2.02,9.01 0000950170-25-068534 001-41855 25932539 34 631222 1 1
2025-04-28 ARS ARS 0000950170-25-059377 001-41855 25881232 34 1420333
2025-04-28 DEFA14A DEFA14A 0000950170-25-059376 001-41855 25881220 34 1157364
2025-04-28 DEF 14A DEF 14A 0000950170-25-059375 001-41855 25881207 34 2112248
2025-04-28 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-040177 005-94231 25880171 34 18001
2025-04-09 4 xslF345X05/form4-04092025_090458.xml 0001415889-25-010505 5065
2025-04-09 4 xslF345X05/form4-04092025_090405.xml 0001415889-25-010503 5059
2025-04-09 4 xslF345X05/form4-04092025_090448.xml 0001415889-25-010501 5116
2025-04-07 8-K 8-K 7.01,8.01,9.01 0000950170-25-051345 001-41855 25816270 34 11889439 1 1
2025-04-01 4 xslF345X05/form4-04012025_110414.xml 0001415889-25-009450 4958
2025-03-24 S-8 POS S-8 POS 0000950170-25-043855 333-286040 25764373 33 675187
2025-03-24 424B5 424B5 0001193125-25-060883 333-283781 25762233 33 394545
2025-03-24 S-8 S-8 0000950170-25-043488 333-286040 25762200 33 697494
2025-03-24 10-K 10-K 0000950170-25-043486 001-41855 25762197 34 17831204 1 1
2025-03-24 8-K 8-K 2.02,9.01 0000950170-25-043485 001-41855 25762195 34 695146 1 1
2025-02-21 4 xslF345X05/form4-02212025_100221.xml 0001415889-25-005113 4920
2025-02-21 4 xslF345X05/form4-02212025_100238.xml 0001415889-25-005110 4958
2025-02-21 4 xslF345X05/form4-02212025_100209.xml 0001415889-25-005109 4893
2025-02-21 4 xslF345X05/form4-02212025_100240.xml 0001415889-25-005108 4901
2025-02-19 144 xsl144X01/primary_doc.xml 0001959173-25-001142 001-41855 25640511 33 4583
2025-02-19 144 xsl144X01/primary_doc.xml 0001959173-25-001141 001-41855 25640329 33 4498
2025-02-19 144 xsl144X01/primary_doc.xml 0001959173-25-001138 001-41855 25640220 33 4629
2025-02-19 144 xsl144X01/primary_doc.xml 0001959173-25-001134 001-41855 25639952 33 4485
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001580642-25-001011 005-94231 25625398 34 13867
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000055 005-94231 25625308 34 10696
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-020474 005-94231 25623651 34 20842
2025-02-13 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-019457 005-94231 25617901 34 248102
2025-02-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-000869 005-94231 25612644 34 12432
2025-02-04 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0002012383-25-000640 005-94231 25587809 34 11785
2025-01-22 4 xslF345X05/form4-01222025_040101.xml 0001415889-25-001859 7650
2025-01-13 8-K 8-K 8.01 0000950170-25-004566 001-41855 25524819 34 12811959 1 1
2025-01-10 4 xslF345X05/form4-01102025_040110.xml 0001415889-25-001287 7660
2025-01-10 4 xslF345X05/form4-01102025_040108.xml 0001415889-25-001286 7655
2025-01-10 4 xslF345X05/form4-01102025_040106.xml 0001415889-25-001285 7661
2025-01-10 4 xslF345X05/form4-01102025_040103.xml 0001415889-25-001284 7706
2025-01-10 4 xslF345X05/form4-01102025_040101.xml 0001415889-25-001283 7641
2024-12-27 3 xslF345X02/form3-12272024_071252.xml 0001415889-24-030197 8149
2024-12-19 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-12-19 09:00:00 9999999995-24-003844 333-283781 241564898 33 1753
2024-12-19 8-K 8-K 5.02,9.01 0000950170-24-138224 001-41855 241560962 34 543585 1 1
2024-12-17 CORRESP filename1.htm 0001193125-24-280121 7110
2024-12-16 UPLOAD filename1.pdf 0000000000-24-013820 333-283781 40024
2024-12-13 S-3 S-3 0001193125-24-277929 333-283781 241546872 33 732676
2024-12-12 4 xslF345X05/form4-12122024_051206.xml 0001415889-24-029143 9542
2024-12-10 144 xsl144X01/primary_doc.xml 0001968582-24-001158 001-41855 241539425 33 5986
2024-12-03 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001193125-24-269008,2024-12-03 9999999995-24-003642 333-278566 241524628 33 1766
2024-12-02 POS AM POS AM 0001193125-24-269008 333-278566 241519985 33 297010
2024-11-26 4 xslF345X05/form4-11262024_051101.xml 0001415889-24-027746 4944
2024-11-14 SC 13G/A SC 13G/A 0001104659-24-119329 005-94231 241464780 34 62111
2024-11-14 SC 13G/A SC 13G/A 0001193125-24-258717 005-94231 241463658 34 72961
2024-11-14 SC 13G/A JANUS AMENDMENT 0001274173-24-000116 005-94231 241459437 34 13044
2024-11-14 SC 13G/A SC 13G/A 0001580642-24-006954 005-94231 241459329 34 55915
2024-11-13 4 xslF345X05/form4-11132024_101138.xml 0001415889-24-026739 5529
2024-11-13 4 xslF345X05/form4-11132024_101126.xml 0001415889-24-026737 9542
2024-11-13 3 xslF345X02/form3-11132024_101152.xml 0001415889-24-026735 7895
2024-11-13 424B3 424B3 0000950170-24-125944 333-278566 241451196 33 2033599
2024-11-13 10-Q 10-Q 0000950170-24-125943 001-41855 241451194 34 8685105 1 1
2024-11-13 424B3 424B3 0000950170-24-125941 333-278566 241451192 33 450930
2024-11-13 8-K 8-K 2.02,5.02,9.01 0000950170-24-125940 001-41855 241451187 34 668684 1 1
2024-11-12 SC 13G LEXEO THERAPEUTICS, INC. 0000902664-24-006396 005-94231 241444184 34 66652
2024-10-30 424B3 424B3 0000950170-24-118570 333-278566 241407266 33 10848562
2024-10-30 8-K 8-K 8.01,9.01 0000950170-24-118569 001-41855 241407263 34 10972730 1 1
2024-10-15 4 xslF345X05/form4-10152024_011001.xml 0001415889-24-025110 9544
2024-10-09 424B3 424B3 0000950170-24-113765 333-278566 241363100 33 22962857
2024-10-09 8-K 8-K 8.01,9.01 0000950170-24-113764 001-41855 241363091 34 23086320 1 1
2024-09-11 4 xslF345X05/form4-09112024_090900.xml 0001415889-24-023233 9546
2024-09-10 144 xsl144X01/primary_doc.xml 0001968582-24-000808 001-41855 241290529 33 6657
2024-08-13 4 xslF345X05/form4-08132024_100801.xml 0001415889-24-021245 9545
2024-08-12 424B3 424B3 0000950170-24-095061 333-278566 241194722 33 3025938
2024-08-12 10-Q 10-Q 0000950170-24-095057 001-41855 241194702 34 9371615 1 1
2024-08-12 8-K 8-K 2.02,9.01 0000950170-24-095054 001-41855 241194694 34 627829 1 1
2024-08-09 SC 13G/A SC 13G 0001580642-24-004416 005-94231 241190672 34 81900
2024-08-05 SC 13G/A JANUS HENDERSON OWNS LEXEO 0001274173-24-000075 005-94231 241173953 34 12950
2024-07-15 424B3 424B3 0000950170-24-083388 333-278566 241115886 33 16545234
2024-07-15 8-K 8-K 8.01,9.01 0000950170-24-083386 001-41855 241115879 34 16697179 1 1
2024-07-12 4 xslF345X05/form4-07122024_040703.xml 0001415889-24-019526 15038
2024-07-08 4 xslF345X05/form4-07082024_100700.xml 0001415889-24-019380 5547
2024-07-08 3 xslF345X02/form3-07082024_100703.xml 0001415889-24-019377 7922
2024-07-08 424B3 424B3 0000950170-24-081945 333-278566 241103341 33 315951
2024-07-08 8-K 8-K 5.02,8.01,9.01 0000950170-24-081942 001-41855 241103337 34 520588 1 1
2024-06-28 424B3 424B3 0000950170-24-078776 333-278566 241081392 33 58097
2024-06-28 8-K 8-K 5.07 0000950170-24-078774 001-41855 241081373 34 161495 1 1
2024-06-27 4 xslF345X05/form4-06272024_090642.xml 0001415889-24-018349 10324
2024-06-27 4 xslF345X05/form4-06272024_090634.xml 0001415889-24-018348 10300
2024-06-27 4 xslF345X05/form4-06272024_090647.xml 0001415889-24-018347 10282
2024-06-27 4 xslF345X05/form4-06272024_090651.xml 0001415889-24-018346 10349
2024-06-27 4 xslF345X05/form4-06272024_090603.xml 0001415889-24-018343 10324
2024-06-14 4 4 0000950170-24-073371 7343
2024-06-12 4 xslF345X05/form4-06122024_050602.xml 0001415889-24-016518 11532
2024-05-22 3 3 0000950170-24-063572 13537
2024-05-14 4 4 0000950170-24-059506 18421
2024-05-13 144 xsl144X01/primary_doc.xml 0001968582-24-000368 001-41855 24940306 33 5210
2024-05-09 424B3 424B3 0000950170-24-056262 333-278566 24928522 33 1650101
2024-05-09 8-K 8-K 2.02,9.01 0000950170-24-056260 001-41855 24928516 34 596789 1 1
2024-05-09 10-Q 10-Q 0000950170-24-056247 001-41855 24928482 34 7342657 1 1
2024-04-26 ARS ARS 0000950170-24-048664 001-41855 24878846 34 2087869
2024-04-26 DEFA14A DEFA14A 0000950170-24-048663 001-41855 24878838 34 1124144
2024-04-26 DEF 14A DEF 14A 0000950170-24-048662 001-41855 24878833 34 1951799
2024-04-22 424B3 424B3 0000950170-24-046200 333-278566 24859570 33 434722
2024-04-22 424B3 424B3 0000950170-24-046199 333-278566 24859564 33 51241
2024-04-22 8-K 8-K 1.01,8.01,9.01 0000950170-24-046197 001-41855 24859562 34 553064 1 1
2024-04-22 8-K FORM 8-K 5.02 0000950123-24-003417 001-41855 24859555 34 153929 1 1
2024-04-16 424B3 424B3 0000950170-24-044601 333-278566 24846113 33 412524
2024-04-16 8-K 8-K 8.01,9.01 0000950170-24-044598 001-41855 24846108 34 463089 1 1
2024-04-12 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2024-04-12 16:30:00 9999999995-24-000964 333-278566 24843019 33 1752
2024-04-12 424B3 424B3 0001193125-24-094850 333-278566 24842251 33 5967705
2024-04-11 CORRESP filename1.htm 0001193125-24-092551 6734
2024-04-11 UPLOAD filename1.pdf 0000000000-24-003913 333-278566 40309
2024-04-09 S-1 S-1 0001193125-24-090233 333-278566 24831181 33 16538956 1 1
2024-03-11 8-K 8-K 1.01,2.02,3.02,7.01,9.01 0000950170-24-029249 001-41855 24738112 34 1089501 1 1
2024-03-11 S-8 S-8 0000950170-24-029222 333-277816 24738051 33 409680
2024-03-11 10-K 10-K 0000950170-24-028941 001-41855 24736761 34 13904448 1 1
2024-02-14 SC 13G/A SC 13G/A 0001104659-24-023927 005-94231 24639964 34 137883
2024-02-14 SC 13G SC 13G 0001193125-24-036405 005-94231 24639562 34 137658
2024-02-14 SC 13G SC 13G 0001104659-24-023824 005-94231 24639285 34 66158
2024-02-14 SC 13G JHG PLZ OWNS >5% 0001274173-24-000061 005-94231 24635666 34 10486
2024-02-14 SC 13G LEXEO THERAPEUTICS, INC. 0000902664-24-001520 005-94231 24631844 34 65983
2024-02-13 SC 13G SC 13G 0001193125-24-033858 005-94231 24626874 34 89814
2024-02-06 3 FORM 3 SUBMISSION 0001209191-24-002931 10633
2024-02-06 4 FORM 4 SUBMISSION 0001209191-24-002930 5526
2024-02-06 4 FORM 4 SUBMISSION 0001209191-24-002929 5555
2024-02-06 4 FORM 4 SUBMISSION 0001209191-24-002928 7698
2024-02-05 8-K 8-K 7.01,9.01 0000950170-24-011005 001-41855 24593931 34 525402 1 1
2024-01-09 4 4 0000950170-24-003466 7449
2024-01-09 4 4 0000950170-24-003464 7337
2023-12-18 8-K 8-K 7.01,9.01 0000950170-23-070935 001-41855 231492222 34 467462 1 1
2023-12-15 SC 13G/A SC 13G/A 0001193125-23-296742 005-94231 231491072 34 45103
2023-12-11 SC 13G SC 13G 0001580642-23-006642 005-94231 231478928 34 56048
2023-12-11 8-K 8-K 2.02,9.01 0000950170-23-069193 001-41855 231476898 34 701832 1 1
2023-12-11 10-Q 10-Q 0000950170-23-069192 001-41855 231476897 34 8940942 1 1
2023-11-24 SC 13G SC 13G 0001193125-23-282769 005-94231 231436998 34 40241
2023-11-17 SC 13G SC 13G 0001104659-23-119530 005-94231 231419084 34 143254
2023-11-09 4 FORM 4 SUBMISSION 0001209191-23-054913 20244
2023-11-09 4 FORM 4 SUBMISSION 0001209191-23-054910 7331
2023-11-09 4 FORM 4 SUBMISSION 0001209191-23-054907 12957
2023-11-09 4 FORM 4 SUBMISSION 0001209191-23-054904 19411
2023-11-07 S-8 S-8 0001193125-23-272561 333-275374 231385061 33 94356
2023-11-07 8-K 8-K 5.03,9.01 0001193125-23-272430 001-41855 231383819 34 157823
2023-11-06 SEC STAFF LETTER filename1.pdf 9999999997-23-004630 64028
2023-11-06 424B4 424B4 0001193125-23-271432 333-274777 231380571 33 9094672
2023-11-03 FWP FWP 0001193125-23-269627 333-274777 231374220 34 9630
2023-11-02 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2023-11-02 16:00:00 9999999995-23-003175 333-274777 231374363 33 1731
2023-11-02 3 FORM 3 SUBMISSION 0001209191-23-054282 11100
2023-11-02 3 FORM 3 SUBMISSION 0001209191-23-054280 10443
2023-11-02 3 FORM 3 SUBMISSION 0001209191-23-054278 17641
2023-11-02 3 FORM 3 SUBMISSION 0001209191-23-054276 12670
2023-11-02 3 FORM 3 SUBMISSION 0001209191-23-054275 6082
2023-11-02 3 FORM 3 SUBMISSION 0001209191-23-054273 19020
2023-11-02 3 FORM 3 SUBMISSION 0001209191-23-054267 6573
2023-11-02 3 FORM 3 SUBMISSION 0001209191-23-054264 6601
2023-11-02 3 FORM 3 SUBMISSION 0001209191-23-054260 7841
2023-11-02 3 FORM 3 SUBMISSION 0001209191-23-054259 8710
2023-11-02 3 FORM 3 SUBMISSION 0001209191-23-054258 9077
2023-11-02 3 FORM 3 SUBMISSION 0001209191-23-054257 6616
2023-11-02 3 FORM 3 SUBMISSION 0001209191-23-054256 11482
2023-11-02 CERT 8A_cert_LXEO.pdf 0001354457-23-000803 001-41855 231373431 34 179773
2023-11-01 CORRESP filename1.htm 0001193125-23-268318 16699
2023-11-01 S-1/A S-1/A 0001193125-23-268301 333-274777 231369042 33 9230143
2023-11-01 8-A12B 8-A12B 0001193125-23-268168 001-41855 231368104 34 14261
2023-11-01 UPLOAD filename1.pdf 0000000000-23-011955 44514
2023-10-31 CORRESP filename1.htm 0001193125-23-267298 10475
2023-10-31 CORRESP filename1.htm 0001193125-23-267290 9030
2023-10-30 S-1/A S-1/A 0001193125-23-265646 333-274777 231357145 33 10444529
2023-10-05 CORRESP filename1.htm 0001193125-23-251767 78054
2023-09-29 S-1 S-1 0001193125-23-247367 333-274777 231295400 33 11773964
2023-09-19 SEC STAFF LETTER filename1.pdf 9999999997-23-004208 65374
2023-09-18 DRSLTR filename1.htm 0000950123-23-008567 24014
2023-09-18 DRS/A filename1.htm 0000950123-23-008566 377-05985 231261464 33 10485282
2023-08-18 UPLOAD filename1.pdf 0000000000-23-009040 46852
2023-08-16 DRS/A filename1.htm 0000950123-23-008288 377-05985 231176284 33 9143767
2023-08-15 DRSLTR filename1.htm 0000950123-23-008284 27790
2023-06-13 UPLOAD filename1.pdf 0000000000-23-006355 50468
2023-05-17 DRSLTR filename1.htm 0000950123-23-005541 22584
2023-05-17 DRS/A filename1.htm 0000950123-23-005540 377-05985 23932008 33 8320110
2022-05-17 UPLOAD filename1.pdf 0000000000-22-005394 46999
2022-05-05 DRSLTR filename1.htm 0000950123-22-004600 61267
2022-05-05 DRS/A filename1.htm 0000950123-22-004599 377-05985 22894484 33 6703686
2022-03-03 UPLOAD filename1.pdf 0000000000-22-002410 65856
2022-02-04 DRS filename1.htm 0000950123-22-001044 377-05985 22594435 33 5432124

Latest XBRL company facts

One latest value per concept from companyfacts (202 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 82.79M 2026-11-12 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
dei EntityPublicFloat Entity Public Float USD 216.50M 2025-06-30 2025 FY 10-K 2026-03-30 0001193125-26-132085
ffd NetFeeAmt NetFeeAmt USD 15,952.56 2026-10-28 S-3 2026-10-29 0001193125-26-437001
ffd TtlFeeAmt TtlFeeAmt USD 15,952.56 2026-10-28 S-3 2026-10-29 0001193125-26-437001
ffd TtlOfferingAmt TtlOfferingAmt USD 300.00M 2026-10-28 S-3 2026-10-29 0001193125-26-437001
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-10-28 S-3 2026-10-29 0001193125-26-437001
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-10-28 S-3 2026-10-29 0001193125-26-437001
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 3.69M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD -19,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap AccruedBonusesCurrent Accrued Bonuses, Current USD 1.03M 2025-03-31 2025 Q1 10-Q 2025-05-12 0000950170-25-068536
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 1.08M 2023-12-31 2023 FY 10-K 2024-03-11 0000950170-24-028941
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 974,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -465,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 681.66M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt USD 4.42M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-24 0000950170-25-043486
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 12.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap Assets Assets USD 243.92M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap AssetsCurrent Assets, Current USD 204.93M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 188,000 2025-12-31 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 465,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 129.38M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five USD 0 2025-09-30 2025 Q3 10-Q 2025-11-05 0001193125-25-265757
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One USD 81.77M 2025-09-30 2025 Q3 10-Q 2025-11-05 0001193125-25-265757
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 128.91M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 104.56M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap AvailableForSaleSecuritiesDebtSecuritiesNoncurrent Debt Securities, Available-for-sale, Noncurrent USD 24.35M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 141,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-11 0000950170-24-028941
us-gaap CapitalizedComputerSoftwareGross Capitalized Computer Software, Gross USD 100,000 2024-12-31 2024 FY 10-K 2025-03-24 0000950170-25-043486
us-gaap CapitalUnitsAuthorized Capital Units, Authorized shares 510.00M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 90.22M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 219.10M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 93.47M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 27.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 33.84M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 500.00M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 82.79M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 82.79M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap CommonStockValue Common Stock, Value, Issued USD 8,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -85.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap ConversionOfStockAmountIssued1 Conversion of Stock, Amount Issued USD 185.03M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-24 0000950170-25-043486
us-gaap ConvertibleNotesPayableCurrent Convertible Notes Payable, Current USD 4.15M 2023-09-30 2023 Q3 10-Q 2023-12-11 0000950170-23-069192
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 4.42M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-24 0000950170-25-043486
us-gaap DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction USD 24,000 2024-01-01 2024-06-30 2025 Q2 10-Q 2025-08-14 0000950170-25-108427
us-gaap DeferredCostsCurrentAndNoncurrent Deferred Costs USD 0 2024-12-31 2024 FY 10-K 2025-03-24 0000950170-25-043486
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 2.44M 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-132085
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 121.37M 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-132085
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 43.72M 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-132085
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-132085
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 2.44M 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-132085
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 56.87M 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-132085
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 6.22M 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-132085
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 7.19M 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-132085
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 118.94M 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-132085
us-gaap DeferredTaxLiabilitiesLeasingArrangements Deferred Tax Liabilities, Leasing Arrangements USD 2.06M 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-132085
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 380,000 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-132085
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 233,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap DividendsCommonStockCash Dividends, Common Stock, Cash USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.99 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.99 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-132085
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-132085
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.165 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-132085
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure -0.005 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-24 0000950170-25-043486
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0.01 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-132085
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure -0.01 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-24 0000950170-25-043486
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.107 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-24 0000950170-25-043486
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure -0.037 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-24 0000950170-25-043486
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 0.055 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-132085
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 20.80M 2024-09-30 2024 Q3 10-Q 2024-11-13 0000950170-24-125943
us-gaap EquitySecuritiesFVNINoncurrent EquitySecuritiesFVNINoncurrent USD 3.39M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap FinanceLeaseInterestExpense Finance Lease, Interest Expense USD 43,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap FinanceLeaseLiability Finance Lease, Liability USD 449,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap FinanceLeaseLiabilityCurrent Finance Lease, Liability, Current USD 420,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap FinanceLeaseLiabilityNoncurrent Finance Lease, Liability, Noncurrent USD 29,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap FinanceLeaseLiabilityPaymentsDue Finance Lease, Liability, Payment, Due USD 468,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap FinanceLeaseLiabilityPaymentsDueAfterYearFive Finance Lease, Liability, to be Paid, after Year Five USD 0 2024-12-31 2024 FY 10-K 2025-03-24 0000950170-25-043486
us-gaap FinanceLeaseLiabilityPaymentsDueNextTwelveMonths Finance Lease, Liability, to be Paid, Year One USD 313,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap FinanceLeaseLiabilityPaymentsDueYearFive Finance Lease, Liability, to be Paid, Year Five USD 0 2024-12-31 2024 FY 10-K 2025-03-24 0000950170-25-043486
us-gaap FinanceLeaseLiabilityPaymentsDueYearFour Finance Lease, Liability, to be Paid, Year Four USD 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap FinanceLeaseLiabilityPaymentsDueYearThree Finance Lease, Liability, to be Paid, Year Three USD 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap FinanceLeaseLiabilityPaymentsDueYearTwo Finance Lease, Liability, to be Paid, Year Two USD 8,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear Finance Lease, Liability, to be Paid, Remainder of Fiscal Year USD 147,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap FinanceLeaseLiabilityUndiscountedExcessAmount Finance Lease, Liability, Undiscounted Excess Amount USD 19,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments USD 398,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap FinanceLeaseRightOfUseAsset Finance Lease, Right-of-Use Asset, after Accumulated Amortization USD 900,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap FinanceLeaseRightOfUseAssetAmortization Finance Lease, Right-of-Use Asset, Amortization USD 240,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap FinanceLeaseWeightedAverageDiscountRatePercent Finance Lease, Weighted Average Discount Rate, Percent pure 0.087 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap GainLossOnFairValueHedgesRecognizedInEarnings Gain (Loss) on Fair Value Hedges Recognized in Earnings USD -530,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-24 0000950170-25-043486
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 21.53M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -99.67M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-132085
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -84.36M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 551,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-132085
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-132085
us-gaap IncomeTaxPaidFederalAfterRefundReceived IncomeTaxPaidFederalAfterRefundReceived USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-132085
us-gaap IncomeTaxPaidStateAndLocalAfterRefundReceived IncomeTaxPaidStateAndLocalAfterRefundReceived USD 551,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-132085
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 16.43M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-132085
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -20.93M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-132085
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 948,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-132085
us-gaap IncomeTaxReconciliationTaxCreditsForeign Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Amount USD 10.60M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-132085
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD -5.52M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-132085
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -1.65M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD 6.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -46,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-11 0000950170-24-028941
us-gaap IncreaseDecreaseInDerivativeAssetsAndLiabilities Increase (Decrease) in Derivative Assets and Liabilities USD -530,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-24 0000950170-25-043486
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -1.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 4.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap IncreaseDecreaseInPropertyAndOtherTaxesPayable Increase (Decrease) in Property and Other Taxes Payable USD -349,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-11 0000950170-24-028941
us-gaap IncreaseDecreaseInSecurityDeposits Increase (Decrease) in Security Deposits USD 2,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-11 0000950170-24-028941
us-gaap InterestExpense Interest Expense USD 72,000 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-12 0000950170-24-095057
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 43,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 104,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-132085
us-gaap InvestmentIncomeAmortizationOfDiscount Investment Income, Amortization of Discount USD 23,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-24 0000950170-25-043486
us-gaap InvestmentIncomeAmortizationOfPremium Investment Income, Amortization of Premium USD 106,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-05 0001193125-25-265757
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 6.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap InvestmentIncomeNetAmortizationOfDiscountAndPremium Investment Income, Net, Amortization of Discount and Premium USD -19,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 6.51M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 0 2024-12-31 2024 FY 10-K 2025-03-24 0000950170-25-043486
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 2.26M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 1.37M 2024-12-31 2024 FY 10-K 2025-03-24 0000950170-25-043486
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 1.37M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 2.32M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 559,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 712,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap Liabilities Liabilities USD 27.23M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 243.92M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap LiabilitiesCurrent Liabilities, Current USD 23.59M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap LongTermInvestments Long-term Investments USD 7.04M 2025-03-31 2025 Q1 10-Q 2025-05-12 0000950170-25-068536
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 40.88M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 53.64M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -67.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -84.36M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 6.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap OperatingExpenses Operating Expenses USD 90.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -90.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap OperatingLeaseCost Operating Lease, Cost USD 1.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 2.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 5.80M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 2.19M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 3.61M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap OperatingLeasePayments Operating Lease, Payments USD 1.65M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 5.37M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 1.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 165,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap OtherAssetsCurrent Other Assets, Current USD 3,000 2023-12-31 2023 FY 10-K 2024-03-11 0000950170-24-028941
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD -653,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -16,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 86,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-24 0000950170-25-043486
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 1.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 31.95M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 340,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap PaymentsToAcquireSoftware Payments to Acquire Software USD 13,000 2024-01-01 2024-09-30 2025 Q3 10-Q 2025-11-05 0001193125-25-265757
us-gaap PreferredStockConvertibleSharesIssuable PreferredStockConvertibleSharesIssuable shares 13.56M 2023-11-07 2024 FY 10-K 2025-03-24 0000950170-25-043486
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 10.14M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 2.83M 2023-12-31 2023 FY 10-K 2024-03-11 0000950170-24-028941
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 4.00M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-24 0000950170-25-043486
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 80.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-132085
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 39.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 185.56M 2021-08-10 2023-11-07 2024 FY 10-K 2025-03-24 0000950170-25-043486
us-gaap ProceedsFromIssuanceOfPreferredStockAndPreferenceStock Proceeds from Issuance of Preferred Stock and Preference Stock USD 20,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-11 0000950170-24-028941
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 95.00M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-30 0001193125-26-132085
us-gaap ProceedsFromSaleMaturityAndCollectionsOfInvestments Proceeds from Sale, Maturity and Collection of Investments USD 85.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 329,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 2.45M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -84.36M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 2.70M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 1.73M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 69.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 3.25M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -464.50M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 654,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-11 0000950170-24-028941
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 12.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 0.85 2023-11-07 2024 FY 10-K 2025-03-24 0000950170-25-043486
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value USD/shares 5.46 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap SharesOutstanding Shares, Outstanding shares 33.06M 2024-09-30 2024 Q3 10-Q 2024-11-13 0000950170-24-125943
us-gaap ShortTermInvestments Short-term Investments USD 70.92M 2025-03-31 2025 Q1 10-Q 2025-05-12 0000950170-25-068536
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 216.69M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 185.03M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-24 0000950170-25-043486
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 2.45M 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 3.69M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 320,000 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap StockRepurchasedDuringPeriodValue Stock Repurchased During Period, Value USD 17,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-30 0001193125-26-132085
us-gaap TaxesPayableCurrent Taxes Payable, Current USD 36,000 2024-06-30 2024 Q2 10-Q 2024-08-12 0000950170-24-095057
us-gaap TemporaryEquityLiquidationPreference Temporary Equity, Liquidation Preference USD 185.56M 2023-11-07 2024 FY 10-K 2025-03-24 0000950170-25-043486
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 143.65M 2023-11-07 2024 FY 10-K 2025-03-24 0000950170-25-043486
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 143.65M 2023-11-07 2024 FY 10-K 2025-03-24 0000950170-25-043486
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 143.65M 2023-11-07 2024 FY 10-K 2025-03-24 0000950170-25-043486
us-gaap TreasuryStockCommonShares Treasury Stock, Common, Shares shares 3,827 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap TreasuryStockCommonValue Treasury Stock, Common, Value USD 17,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap UnrealizedGainLossOnInvestments Unrealized Gain (Loss) on Investments USD -653,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-132085
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-132085
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 23.50M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001193125-26-132085
us-gaap VariableLeaseCost Variable Lease, Cost USD 387,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 85.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 85.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020
us-gaap WorkersCompensationLiabilityCurrent Workers' Compensation Liability, Current USD 3.54M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462020

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →